This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The enactment of adult-use cannabis legalization laws in Colorado and Washington is associated with increased tourism in both states, according to data published in the Journal of Regional Analysis & Policy. Additional information appears in the NORML fact-sheet , “Marijuana Regulation: Impact on Health, Safety, and Economy.”
The enactment of state-specific medical cannabis access laws is associated with a decline in workers’ compensation claims, according to data published in the journal Health Economics. ” They concluded: “Our findings add to the small, but growing, literature on the effects of MMLs on labor market outcomes.
A brand new study featured in the journal Drug and Alcohol Dependence delivered exciting news to psychiatrists, health professionals, and law enforcement officials across the United States and beyond. The investigation assessed the suitability of using smartphone sensor data to detect cannabis intoxication, and it had promising results.
The enactment of statewide legislation permitting adult cannabis possession and sales is not associated with any significant or long-term uptick in criminal activity, according to data published in the journal Justice Quarterly. Additional information is available from the NORML fact-sheet , ‘Marijuana Regulation and Crime Rates.’
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Administrative costs of initiating new laws. General funds.
The New York State Association of Police said traffic safety is a major concern, citing an increase in vehicle-related fatalities by 62 percent in Colorado the first year cannabis was legalized in the state. Please visit www.rocnorml.org for more information about how you can get involved and follow ROC NORML on Facebook and Twitter. .
” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. ” For more information on the public health and safety of cannabis, please see NORML’s fact-sheets here.
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. Forward-Looking Statements.
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 The history of the law surrounding this subject may offer insight. Therefore, the law prohibited the utilization of even medical marijuana.
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
“This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”. McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding. They’re in a unique space,” McDonell said of the Puyallup tribe.
Law enforcement, policy makers, and public citizens have long debated how recreational marijuana legalization influences crime and public safety. Data tells us that more arrests for marijuana trafficking and possession occur after marijuana legalization in neighboring states, concentrated at the bordering counties.
What law legalized medical marijuana in Florida? How does Florida law define medical marijuana? SHORT ANSWER: Low-THC cannabis , defined by Florida law, only contains 8% or less THC and more than 10% CBD. To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies.
Last Thursday, a collation of twenty-six House members sent a letter to the FDA, urging the agency to develop a path for the lawful marketing of Hemp-CBD products. The spending reports mandates the FDA to clear a path for the lawful marketing of these products within 120 days. House of Representatives.
Despite its multi-year process of assessing potential exceptions from the Drug Preclusion and evaluating the safety and science of CBD, the FDA has not changed its prohibitive approach. However, the plain language of the Drug Preclusion, supporting case law ( see Pharmanex, Inc. SafetyData Matters. Shalala , 35 F.
In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly. As FDA Principal Deputy Commissioner Amy Abernathy remarked, the FDA will “take action as needed against companies that violate the law in ways that raise a variety of public health concerns.”
This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. Furthermore, the measurement of available data elements can be affected by very context of marijuana legalization. 13-283 (C.R.S.
As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. The map below seeks to track these initiatives.
Luckily, states such as Colorado, Washington, and California have had marijuana laws in place long enough for researchers to collect data and better understand the effects of legalization on behaviors such as driving under the influence. Their results may assuage some of these concerns. FACTORS INFLUENCING RESULTS. INADEQUATE TESTING.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. Furthermore, the measurement of available data elements can be affected by very context of marijuana legalization. 13-283 (C.R.S.
are increasingly relaxing their cannabis laws, it’s no surprise that the drug’s consumption has grown , especially among American workers. Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. As many states across the U.S.
Hoban Law Group is delighted to announce that Managing Attorney Garrett Graff was selected by the U.S. at the Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing on Friday, May 31, 2019. FDA Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.
(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.
For the past six months, the federal agency has been bombarded with messages, urging the FDA to promptly develop a regulatory pathway for the lawful use of hemp-derived CBD (“Hemp-CBD”) in foods and dietary supplements. The Food and Drug Administration (“FDA”) seems to be listening.
FDA’s actions send a discouraging message to the entire hemp and CBD industry, especially in light of the fact that these firms provided more than ample safetydata and cooperated with FDA’s requests throughout the process.
Data from the Denver District Attorney’s office shows only 47 cases related to psychedelic mushrooms since May 2019 decriminalization. The panel that includes District Attorney Beth McCann, law enforcement officers and psilocybin advocate Kevin Matthews was formed after 2019, when Denver voters were the first in the U.S.
Data shows that commercial drivers are consuming cannabis more than any other drug, even if it can ruin their career. Commercial drivers test positive for cannabis more often these days than any other drug, according to the latest data from the U.S. But the FMCSA doesn’t care about state laws. View original article.
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.
This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link]. Tweet this.
La Jolla, CA: The establishment of licensed cannabis retailers is not independently associated with an increase in traffic crashes, according to data published in the journal Health Economics.
Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. Following the March 31, 2021 deadline, only products for which a valid application has been submitted will be allowed to remain on the market.
But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.
Crash rates spiked with the legalization of recreational marijuana use and retail sales in California, Colorado, Nevada, Oregon and Washington, a new study by the Insurance Institute for Highway Safety (IIHS) and another by the affiliated Highway Loss Data Institute (HLDI) show. Insurance Institute for Highway Safety.
General Counsel Jonathan Miller Raises Concerns Regarding FDA’s Stance on CBD Regulation WASHINGTON D.C. — On the heels of last week’s U.S. Food and Drug Administration (FDA) webinar for hemp industry stakeholders, “A New Way Forward for Cannabidiol and Other Hemp Products,” U.S.
as a dietary supplement, prior to October 15, 1994, the date that the Dietary Supplement Health and Education Act became law. Still About Safety. Two and a half years since the passage of the 2018 Farm Bill, the FDA’s recent refusals make clear that the agency has unresolved safety concerns. Not About Enforcement.
Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of federal law, but also can put consumers at risk, as these products have not been proven to be safe or effective. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans.
An example of these laboratories is Praxis Laboratory which was said to have provided falsified testing data for more than 1,200 cannabis products. Their statements also included something to likes of an employee stealing data and then contacting the regulators.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content